. Author manuscript; available in PMC: 2023 Mar 11.

Published in final edited form as: Nat Rev Neurol. 2011 Apr 12;7(5):263–272. doi: 10.1038/nrneurol.2011.43

Table 1 |.

Clinical heterogeneity of pathologically confirmed CBD

Reference	Female:male ratio	Age at onset/disease duration (years)	Common features at onset (% of patients)					Clinical diagnosis^* (% of patients)

			Limb apraxia	Memory impairment	Behavioral changes	Gait disturbance	Speech disorder	CBS	AD or PD	FTD	RS

Schneider et al. (1997)¹⁸	10:1	67/7.9	64	18	9	9	9	64	27	0	0
Litvan et al. (2000)²⁶	14:13	64/7.0	37	33	33	26	22	22	30	7	4
Murray et al. (2007)¹⁶	8:7	61/5.4	33	33	40	27	40	40	13	33	13
Ling et al. (2010)¹⁷	9:10	66/6.0	26	37	26	63	16	26	10	5	42
Totals	41:31	65/6.6	38	32	29	33	22	33	21	11	15

The total does not equal 100% because some series had final diagnoses other than the diseases listed here. Abbreviations: AD, Alzheimer disease; CBD, corticobasal degeneration; CBS, corticobasal syndrome; FTD, frontotemporal dementia; PD, Parkinson disease; RS, Richardson syndrome.